Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

The perimenopausal hot flash: epidemiology, physiology, and treatment

Article Abstract:

Many women experience frequent, uncomfortable hot flashes before and during menopause. This vasomotor instability may be prevented with hormone replacement therapy. An estrogen/progestin combination not only mitigates or relieves hot flashes, but also helps prevent osteoporosis and coronary heart disease. Low-dose oral contraceptives may prevent hot flashes in premenopausal women. Phytoestrogens, found in soy and other plant products, appear beneficial as well. Keeping a hot flash diary may help some women recognize and avoid dietary, psychological or environmental triggers.

Author: Shaw, Christine R.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: The Nurse Practitioner
Subject: Health
ISSN: 0361-1817
Year: 1997
Physiological aspects, Menopause

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Ipratropium bromide (Atrovent) nasal spray: a new treatment for rhinorrhea

Article Abstract:

A nasal spray containing one of two ipratropium bromide (IP) strengths appears to be effective in patients with runny noses. Studies have shown IP nasal spray to significantly reduce the number of times that patients' noses need blowing. The stronger formulation may be appropriate for runny noses associated with the common cold while the weaker formulation may be appropriate for patients with allergies. Reported side effects include upper respiratory infections, dryness, headaches, and bloody noses.

Author: Pfister, Shirley M.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: The Nurse Practitioner
Subject: Health
ISSN: 0361-1817
Year: 1996
Product/Service Evaluation, Nose, Bodily secretions, Atrovent (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Prostaglandin analogues: a new classification of ocular hypotensive agents used in the treatment of glaucoma

Article Abstract:

Glaucoma is treatable by use of latanoprost, the first approved drug of a a group of newly classified ocular hypotensive agents known as prostaglandin analogues. However, long-term study of latanoprost's effect on iris pigmentation is required, although other side-effects appear to be mild. The drug, which can be combined with similar agents, lowers intraocular pressure effectively if used once a day.

Author: Gallucci, Gretchen M.
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: The Nurse Practitioner
Subject: Health
ISSN: 0361-1817
Year: 1996
Health aspects, Drug therapy, Prostaglandins, Antihypertensive drugs, Antihypertensive agents, Glaucoma

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Evaluation
Similar abstracts:
  • Abstracts: Epstein-Barr virus infections: biology, pathogenesis, and management. part 2 Superantigens and microbial pathogenesis
  • Abstracts: Hantavirus pulmonary syndrome: epidemiology, prevention, and case presentation of a new viral strain
  • Abstracts: The big wheeze. Adult screening for depression
  • Abstracts: Clinical recognition and management of adult attention deficit hyperactivity disorder. part 2 Legal and practical impact of clinical practice guidelines on nursing and medical practice
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.